There is a phrase in food regulation that sounds more harmless than it actually is. Self-affirmed GRAS. For decades, it has let a company decide, on its own, that a new ingredient is safe. Its own scientists, its own documentation, its own panel. No requirement to notify the FDA. No public record. Just an internal yes.
A March 2026 investigation found more than 100 food chemicals on American shelves that have never been reviewed by anyone outside the company that introduced them. Congress has noticed. Rep. Lawler has a bill in the House. Sen. Marshall has one in the Senate. New York passed its own version in April, banning three ingredients outright and building a public database for every self-affirmed substance sold in the state.
Whether the FDA's own rule survives is genuinely unclear. Legal scholars are already questioning whether the agency has the authority to finalize it. But the direction is set. If any version becomes law, companies get roughly two years to revisit every ingredient they ever cleared themselves and prove it still holds up.
Here is the part nobody in that debate says out loud. Self-affirmed GRAS is a weak process. It is private, slow, and widely considered too thin. But it is a process. A company has to convene a panel of credentialed scientists. It has to produce a documented safety file. Someone has to attest to the decision.